You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for New Drug Application (NDA): 078316

✉ Email this page to a colleague

« Back to Dashboard

NDA 078316 describes OXYCODONE HYDROCHLORIDE AND IBUPROFEN, which is a drug marketed by Actavis Elizabeth, Barr Labs Inc, and Watson Labs, and is included in three NDAs. Additional details are available on the OXYCODONE HYDROCHLORIDE AND IBUPROFEN profile page.

The generic ingredient in OXYCODONE HYDROCHLORIDE AND IBUPROFEN is ibuprofen; oxycodone hydrochloride. There are sixty-four drug master file entries for this compound. Additional details are available on the ibuprofen; oxycodone hydrochloride profile page.

Summary for 078316

Tradename:	OXYCODONE HYDROCHLORIDE AND IBUPROFEN
Applicant:	Barr Labs Inc
Ingredient:	ibuprofen; oxycodone hydrochloride
Patents:	0

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	400MG;5MG
Approval Date:	Nov 29, 2007	TE:		RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.